SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-143035
Filing Date
2021-11-23
Accepted
2021-11-23 16:12:47
Documents
1
Period of Report
2021-11-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2133657-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2133657-1_4seq1.xml 4 3122
  Complete submission text file 0001104659-21-143035.txt   4640
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Komjathy Andrew (Reporting) CIK: 0001788465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 211438654